FDA recommends Cologuard stool-based DNA test for colon cancer after it demonstrates 93.3 pct sensitivty The number of adults getting screened for colon cancer may soon increase as the U.S Food and Drug Administration (FDA) is likely to give its approval to a less invasive stool-based DNA test for detecting colon cancer. by Rhodi Lee
Healthy Living/Wellness New stool-based DNA test screens for colorectal cancer: Say goodbye to colonoscopy by Rhodilee Jean Dolor